{"id":"W4378174753","doi":"10.1111/ene.15891","title":"Ocrelizumab extended‐interval dosing in multiple sclerosis during <scp>SARS‐CoV</scp>‐2 pandemic: a real‐world experience","year":2023,"lang":"en","type":"article","venue":"European Journal of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Ministero della Salute; Multiple Sclerosis Society of Canada; Fondazione Italiana Sclerosi Multipla; Celgene; Novo Nordisk; Sanofi; Horizon Therapeutics; Teva Pharmaceutical Industries; Bristol-Myers Squibb; Eli Lilly and Company; Biogen","keywords":"Medicine; Multiple sclerosis; Ocrelizumab; Dosing; Cohort; Internal medicine; Regimen; Magnetic resonance imaging; Confidence interval; Radiology; Immunology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001025383,0.0001801973,0.0002480728,0.0001488495,0.0002725911,0.0004303275,0.0001679584,0.0003558842,0.0004612017],"category_scores_gemma":[0.002325166,0.00009347106,0.0001865394,0.0002160437,0.0002847826,0.0002687359,0.0002981284,0.0003811625,0.0001438876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003302251,"about_ca_system_score_gemma":0.0002223924,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005088809,"about_ca_topic_score_gemma":0.0004062471,"domain_scores_codex":[0.9994782,0.0002479982,0.00005145588,0.00007537106,0.00007952438,0.00006759415],"domain_scores_gemma":[0.9989474,0.0003452656,0.000327127,0.0001078658,0.00007164833,0.000200614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01137317,0.005658628,0.6229218,0.0005008394,0.0002234371,0.02240023,0.004958509,0.001432983,0.01576914,0.0003289624,0.00176988,0.3126624],"study_design_scores_gemma":[0.001765104,0.06690945,0.8395838,0.0001885424,0.000256279,0.06708574,0.00221283,0.002273771,0.006432159,0.0002277066,0.01300567,0.0000589191],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988068,0.0006497918,0.0001290337,0.00005269961,0.000005547436,0.00001543365,0.00001635537,0.000003009319,0.0003212187],"genre_scores_gemma":[0.999189,0.0004906591,0.0001296736,0.00005914704,0.00002756265,0.000007130954,0.00002960003,0.000001770855,0.00006547024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001025383,"threshold_uncertainty_score":0.005422771,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1515634966275657,"score_gpt":0.3442184315850131,"score_spread":0.1926549349574475,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}